Cemiplimab (Libtayo) for Cutaneous Squamous Cell Carcinoma — Details (Libtayo) (Last Updated: Feb 6, 2020)
Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name
Manufacturer
Submission Type
Indication
Brand Name:
Libtayo
Manufacturer:
Sanofi Genzyme
Submission Type:
Initial